** Shares of Trajan Group Holdings rise as much as 5% to A$1.260, posting their biggest intraday pct gain since Sept. 10

** Life sciences co says Q1 total net revenue up in high single-digit over pcp

** Maintains FY25 net revenue forecast of A$160.0 mln ($105.31 mln) to A$165.0 mln, and group nEBITDA of A$17.0 mln to A$19.0 mln

** Co had reported net revenue of A$155 mln and group normalised EBITDA of A$17.1 mln for fiscal 2024

** Stock hits highest level since Oct. 7

** TRJ up 2% YTD, as of 0225 GMT

($1 = 1.5193 Australian dollars)

(Reporting by Adwitiya Srivastava in Bengaluru)

((Adwitiya.Srivastava@thomsonreuters.com;))